Publicaciones en colaboración con investigadores/as de Hospital Regional Universitario de Málaga (8)

2024

  1. ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-related cancer

  2. Effectiveness of combined first-line medical treatment in acromegaly with prolactin cosecretion

    European Journal of Endocrinology, Vol. 190, Núm. 6, pp. 458-466

  3. Glucose metabolism outcomes after pituitary surgery in patients with acromegaly

    Pituitary

  4. Natural history and surgical outcomes of Rathke’s cleft cysts: a Spanish multicenter study

    Frontiers in Endocrinology, Vol. 15

  5. Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

    Endocrine-Related Cancer, Vol. 31, Núm. 7

2021

  1. The SEEN comprehensive clinical survey of adult obesity: Executive summary

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 2, pp. 130-136

2019

  1. Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study

    Pituitary, Vol. 22, Núm. 2, pp. 137-145

2014

  1. Fe de errores de Guía práctica de diagnóstico y tratamiento de la acromegalia (Endocrinol Nutr. 2013;60(8):457.e1-457.e15)

    Endocrinologia y Nutricion